Drug
Alks 7290 Dose
Alks 7290 Dose: highest development phase Phase 2, developed by Alkermes. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALKS 7290 Dose NCT07901179 | Phase 2 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Alks 7290 Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.